Nirvana Life Sciences Inc. Contracts Stratus Designs for Mechanical Service to Laboratory

Vancouver, British Columbia--(Newsfile Corp. - April 12, 2022) - Nirvana Life Sciences Inc. (CSE: NIRV)  (Nirvana or the "Company"), a Canadian based life sciences company aimed at developing non-addictive chronic pain and relapse preventing products is pleased to announce that it has engaged Stratus Designs Ltd. to undertake design of mechanical and control systems for its Vancouver Lab facility.

Adam Clarke, CEO and Principal Consultant of Stratus commented, "The projects that Nirvana Life Sciences are advancing represent the evolution of modern medicine. Our team will work to ensure that this facility is built to deliver the highest standard of quality for all these initiatives".

Mr. Bruce Clark, Chief Executive Officer of Nirvana commented, "We continue to advance our project, and are pleased that Adam Clarke and the Stratus Design team has chosen to join with us. The expertise he brings in Controls, Automation and Facility Design will be a tremendous asset to our development."

About Stratus Designs Ltd.

Stratus Designs is a BC based automation and mechanical design consultancy that has provided service to more than 40 facilities across Food, Pharmaceutical and Cannabis Industries. Their planning and design services provide crucial guidance through construction and operations phases, resulting in a facility that is optimized for quality and productivity, and designed to meet GACP and GMP standards.

About Nirvana Life Sciences Inc.

Nirvana Life Sciences Inc. has been founded with a simple objective of researching and developing non-addictive pain management and relapse prevention products that can provide healthier outcomes for patients who live with chronic pain and/or have battled with addiction. Nirvana believes that using naturally sourced psychedelics in novel formulations holds the promise of delivering non-addictive solutions that are effective in managing pain and addiction. Nirvana's team, consisting of leading researchers from around the globe, will develop therapies that have the potential of freeing millions from addiction and saving society billions of dollars annually.

For further information:
Bruce Clark- CEO
info@nirvanalifescience.com
Phone: 604-401-8100

Forward Looking Statements

This news release contains certain forward-looking statements and forward-looking information (collectively referred to herein as "forward- looking statements") within the meaning of Canadian securities laws including, without limitation, statements with respect to the future investments by the Company. All statements other than statements of historical fact are forward-looking statements. Undue reliance should not be placed on forward-looking statements, which are inherently uncertain, are based on estimates and assumptions, and are subject to known and unknown risks and uncertainties (both general and specific) that contribute to the possibility that the future events or circumstances contemplated by the forward-looking statements will not occur. Although the Company believes that the expectations reflected in the forward-looking statements contained in this press release, and the assumptions on which such forward-looking statements are made, are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking statements included in this document, as there can be no assurance that the plans, intentions or expectations upon which the forward-looking statements are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause the Company's actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/120165